Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression

Translational Psychiatry

Volumn 4, Issue , 2014, Pages

  Karabatsiakis, A ^a   Bock C ^a   Salinas Manrique, J ^b   Kolassa, S ^c   Calzia, E ^a   Dietrich, D E ^d   Kolassa, I T ^a  

^a UNIVERSITY OF ULM   (Germany)

^b AMEOS Clinic Hildesheim   (Germany)

^c SAP AG   (Switzerland)

^d Burghof Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FATIGUE; FEMALE; HUMAN; HUMAN CELL; IRRITABILITY; LONELINESS; MAJOR DEPRESSION; MENTAL CONCENTRATION; MITOCHONDRIAL RESPIRATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL INACTIVITY; RESPIROMETRY; TURNOVER TIME; CONTROLLED STUDY; MOLECULAR PATHOLOGY; OXIDATIVE PHOSPHORYLATION UNCOUPLING; CASE CONTROL STUDY; CELL RESPIRATION; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; METABOLISM; MIDDLE AGED; MITOCHONDRION; MONONUCLEAR CELL; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; CASE-CONTROL STUDIES; CELL RESPIRATION; CITRATE (SI)-SYNTHASE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MITOCHONDRIA; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84903713915     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.44     Document Type: Article

References (57)

1. 2+ homeostasis: mechanism, role, and tissue specificities. Pflügers Arch 2012; 464: 3-17.
2. Schulz E, Wenzel P, Münzel T, Daiber A. Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 2012; 20: 308-324.
3. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000; 29: 222-230.
4. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003; 112: 481-490. (Pubitemid 36263081)
5. Burroughs S, French D. Depression and anxiety: role of mitochondria. Curr Anaesth Crit Care 2007; 18: 34-41. (Pubitemid 46979866)
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing: Arlington, VA, USA, 2013.
7. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56. (Pubitemid 350295688)
8. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008; 11: 851.
9. Irie M, Asami S, Nagata S, Miyata M, Kasai H. Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health 2001; 74: 153-157. (Pubitemid 32229220)
10. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 2005; 39: 553-560. (Pubitemid 41278622)
11. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-Term antidepressant treatment does not alter oxidative-Antioxidative systems. Hum Psychopharmacol 2007; 22: 67-73. (Pubitemid 46505714)
12. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Bond DJ, Kapczinski F, Young LT et al. Oxidative stress markers in bipolar disorder: a meta-Analysis. J Affect Disord 2008; 111: 135-144.
13. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684-697. (Pubitemid 38932173)
14. Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001; 24: 420-429. (Pubitemid 32157558)
15. Fattal O, Budur K, Vaughan AJ, Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006; 47: 1-7. (Pubitemid 43017115)
16. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29: 311-324.
17. Inczedy-Farkas G, Remenyi V, Gal A, Varga Z, Balla P, Udvardy-Meszaros A et al. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct 2012; 8: 9, 9081-8-9.
18. Rezin GT, Cardoso MR, Gonçalves CL, Scaini G, Fraga DB, Riegel RE et al. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int 2008; 53: 395-400.
19. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000; 101: 11-20. (Pubitemid 30041119)
20. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-682. (Pubitemid 29220063)
21. Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827. (Pubitemid 27181254)
22. Moretti A, Gorini A, Villa R. Affective disorders, antidepressant drugs and brain metabolism. Mol Psychiatry 2003; 8: 773-785. (Pubitemid 37100711)
23. Gardner A, Johansson A, Wibom R, Nennesmo I, von Dobeln U, Hagenfeldt L et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord 2003; 76: 55-68. (Pubitemid 37013356)
24. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34: 301-309.
25. Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun 2011; 25: 221-229.
26. Wolkowitz OM, Reus VI, Mellon SH. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci 2011; 13: 25.
27. Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 2013; 13: 40.
28. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 1995; 29: 141-152.
29. Schwarz M, Müller N, Riedel M, Ackenheil M. The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses 2001; 56: 483-486. (Pubitemid 32397883)
30. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci 2004; 1032: 141-153. (Pubitemid 40298466)
31. Gump BB, Matthews KA, Eberly LE, Chang YF MRFIT Research Group. Depressive symptoms and mortality in men: results from the multiple risk factor intervention trial. Stroke 2005; 36: 98-102. (Pubitemid 40054182)
32. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150: 1115-1121. (Pubitemid 41773510)
33. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B et al. Depression and cardiovascular sequelae in postmenopausal women. the women's health initiative (WHI). Arch Intern Med 2004; 164: 289-298. (Pubitemid 38176467)
34. Molife C. Is depression a modifiable risk factor for diabetes burden? J Prim Care Community Health 2010; 1: 55-61.
35. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003; 54: 269-282. (Pubitemid 37267857)
36. Buttgereit F, Burmester G, Brand MD. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol Today 2000; 21: 194-199.
37. Hroudová J, Fišar Z, Kitzlerová E, Zvěřová M, Raboch J. Mitochondrial respiration in blood platelets of depressive patients. Mitochondrion 2013; 6: 795-800.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edn, text rev.). Washington, DC, USA, 2000.
39. Beck AT Steer R Brown GK. Manual for the Beck Depression Inventory-II. Psychological Cooperation: San Antonio, TX, USA, 1996.
40. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
41. Tagay S, Erim Y, Stoelk B, Möllering A, Mewes R, Senf W. Das Essener Trauma-Inventar (ETI)-Ein Screeninginstrument zur Identifikation traumatischer Ereignisse und posttraumatischer Störungen. Psychother Psych Med 2007; 1: 75-89.
42. Gnaiger E. Mitochondrial Pathways and Respiratory Control. An Introduction to OXPHOS Analysis. OROBOROS MiPNet Publications 2012: Innsbruck, Austria, 2012.
43. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435: 297.
44. Eigentler A, Draxl A, Wiethüchter A, Kuznetsov A, Lassing B, Gnaiger E. Laboratory protocol: citrate synthase. A mitochondrial marker enzyme. MiPNet 2012; 17.04: 1-11.
45. R Core Team. R: A Language and Environment for Statistical Computing. R foundation for statistical computing: Vienna, Austria, 2013.
46. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52: 591-611.
47. Levene H et al. In: Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Olkin, I et al. (eds). Stanford University Press: Stanford, CA, USA, 278-292. 1960.
48. Student. The probable error of a mean. Biometrika 1908; 6: 1-25.
49. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 1947; 18: 50-60.
50. Pearson K. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Phil Mag 1900; 50: 157-175.
51. Kendall MG. A new measure of rank correlation. Biometrika 1938; 30: 81-93.
52. Hroudová J, Fisar Z. Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuroendocrinol Lett 2010; 31: 336-342.
53. Scaini G, Maggi DD, DeNês BT, Gonçalves CL, Ferreira GK, Teodorak BP et al. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neuropsychiatrica 2011; 23: 112-118.
54. Fariello RM, Pariz JR, Spaine DM, Cedenho AP, Bertolla RP, Fraietta R. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int 2012; 110: 863-867.
55. Alonso J, Cardellach F, Casademont J, Miro O. Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking. Eur Resp J 2004; 23: 214-218. (Pubitemid 38195505)
56. Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143: 993-997. (Pubitemid 16073948)
57. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnorm Psychol 2001; 110: 40.